LivaNova PLC (LIVN) — Business segments and KPIs
Revenue by business segment and geography for LivaNova PLC, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Cardiopulmonary Segment | 785.39M | 57.0% |
| Neuromodulation Segment | 592.81M | 43.0% |
| Revenue by region | ||
| UNITED STATES | 739.57M | 53.3% |
| Locations Excluding The United States And Europe | 379.3M | 27.3% |
| Europe | 269.18M | 19.4% |